| Almirall AG - Ebglyss 250 mg/2 ml, Injektionslösung in Fertigspritze |
| 69344 | | 01 | | Ebglyss 250 mg/2 ml | | Injektionslösung in Fertigspritze | | D11AH10 | | | | 30.08.2024 | | |
|
| Composition |
| lebrikizumabum 250 mg, histidinum, acidum aceticum glaciale, saccharum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 2 ml. |
| Packungsbestandteile |
| Injection solution in prefilled syringe | | | | | | | | Active Agent | Dose |
|---|
| Lebrikizumabum | 250mg / 2ml |
| | BAG: Active Agent | Dose |
|---|
| Lebrikizumabum | 250 mg |
| | | | Inactive agents |
|---|
| Acidum Aceticum Glaciale | | Histidine | | Polysorbatum 20 | | Saccharum |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | PR | PR | B | | No | | 002 | 2 | 1916.93 | 2101.20 | B | SL | No |
|
